Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 243 results:
Συντάκτης Τίτλος Τύπος [ Έτος![(Desc)](https://www.med.auth.gr/sites/all/modules/biblio/misc/arrow-desc.png)
Φίλτρα: Συντάκτης is Karagiannis, Asterios [Clear All Filters]
Semaglutide, lipid-lowering drugs, and NAFLD..
Lancet Diabetes Endocrinol. 5(5), 329-330.
(2017). SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature..
Curr Pharm Des. 23(10), 1510-1521.
(2017).
(2017).
(2017). Antihypertensive therapy in acute ischemic stroke: where do we stand?.
J Hum Hypertens. 32(12), 799-807.
(2018). Boosting the Limited Use of Mineralocorticoid Receptor Antagonists Through New Agents for Hyperkalemia..
Curr Pharm Des. 24(46), 5542-5547.
(2018). Diabetes and lipid metabolism..
Hormones (Athens). 17(1), 61-67.
(2018). Dietary management of dyslipidaemias. Is there any evidence for cardiovascular benefit?.
Maturitas. 108, 45-52.
(2018). The effect of antidiabetic medications on the cardiovascular system: a critical appraisal of current data..
Hormones (Athens). 17(1), 83-95.
(2018). Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension..
Curr Vasc Pharmacol. 16(4), 393-400.
(2018). Pharmacotherapy of type 2 diabetes: An update..
Metabolism. 78, 13-42.
(2018). Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?.
J Clin Hypertens (Greenwich). 20(5), 942-948.
(2018). Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?.
J Clin Hypertens (Greenwich). 20(4), 634-636.
(2018). Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice..
Cardiovasc Hematol Disord Drug Targets. 18(2), 139-146.
(2018). Subclinical target organ damage in primary aldosteronism: resistant to spironolactone therapy?.
J Hypertens. 36(3), 701.
(2018). Arterial adaptations in athletes of dynamic and static sports disciplines - a pilot study..
Clin Physiol Funct Imaging. 39(3), 183-191.
(2019). Arterial stiffness correlates with progressive nailfold capillary microscopic changes in systemic sclerosis: results from a cross-sectional study..
Arthritis Res Ther. 21(1), 253.
(2019). Determinants of pulse wave velocity index and potential implementations..
J Clin Hypertens (Greenwich).
(2019). Effect of Nebivolol and Olmesartan on 24-Hour Brachial and Aortic Blood Pressure in the Acute Stage of Ischemic Stroke..
Int J Hypertens. 2019, 9830295.
(2019). The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials..
J Hypertens. 37(7), 1334-1343.
(2019). The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus.
Journal of Hypertension. 1.
(2019). The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotection.
Future Medicinal Chemistry. 2019 Jun;11(11):1285-1303.
(2019). The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotection..
Future Med Chem. 11(11), 1285-1303.
(2019). Effects of lipid lowering drugs on arterial stiffness. One more way to reduce cardiovascular risk?.
Curr Vasc Pharmacol.
(2019). Free Cortisol Is a More Accurate Marker for Adrenal Function and Does Not Correlate with Renal Function in Cirrhosis..
Dig Dis Sci. 64(6), 1686-1694.
(2019).